Stock Exchange & Press Releases 2021

Print Print this release
February 11, 2021

Change in the Bittium Corporation’s Annual Report 2020 Release Date

Stock exchange release

Free for publication on February 11, 2021 at 8.01 am (CET+1)

Change in the Bittium Corporation's Annual Report 2020 Release Date

Bittium Corporation has decided to bring forward the release date of its Annual Report 2020 from the earlier announced on December 15, 2020. Annual Report, which includes Financial Statement, Report by the Board of Directors, Corporate Governance and Sustainability Report will be published on Friday, March 19, 2021. This change will allow shareholders more time to familiarize themselves with the company's financial statements before the Annual General Meeting.

The release dates of the announcement of the financial results and the date of the Annual General Meeting remain unchanged:

  • Financial Statement Bulletin 2020: on February 11, 2021, at 8.00 am (CET+1)
  • The Annual General Meeting 2021: on April 14, 2021 at 1.00 pm (CEST+1).
  • Business Review January-March 2021: on April 29, 2021 at 8.00 am (CEST+1)
  • Half Year Financial Report January – June 2021: on August 6, 2021, at 8.00 am (CEST+1)
  • Business Review January-September 2021: on October 22, 2021 at 8.00 am (CEST+1)

Oulu, February 11, 2021
Bittium Corporation

Further information

Karoliina Malmi
Vice President, Communications and Marketing
Bittium Corporation
Tel. +358 40 344 2789


Nasdaq Helsinki Oy
Main media


Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its 35 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2020 were EUR 78.4 million and operating profit was EUR 2.1 million. Bittium is listed on Nasdaq Helsinki.

Change in the Bittium Corporation's Annual Report 2020 Release Date (wkr0006.pdf)